Victory Capital Management
AMAG

Victory Capital Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Victory Capital Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-9,282
Closed -$58K – 3655
2020
Q1 		$58K Buy
+9,282
New +$81.8K ﹤0.01% 2713
2019
Q4 		– Sell
-5,229
Closed -$60K – 3629
2019
Q3 		$60K Buy
+5,229
New +$55K ﹤0.01% 2608

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management's AMAG Position: Q2 2020 in Review

Victory Capital Management sold out of AMAG Pharmaceuticals (AMAG) in Q2 2020, closing a stake of 9,282 shares — an estimated $58K sold.

Victory Capital Management first reported a position in AMAG in Q3 2019 and held it in 2 quarters. The position peaked at $60K in Q3 2019. 119 funds tracked by Wall St. Rank hold AMAG as of Q2 2020.

  • Victory Capital Management reported no remaining AMAG Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 9,282 AMAG Pharmaceuticals shares in Q2 2020, an estimated $58K.
  • Victory Capital Management first reported a position in AMAG Pharmaceuticals in Q3 2019 and held it in 2 quarters.
  • Victory Capital Management's AMAG Pharmaceuticals position peaked at $60K in Q3 2019.
  • 119 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.